miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma.
Cui T, Bell EH, McElroy J, Becker AP, Gulati PM, Geurts M, Mladkova N, Gray A, Liu K, Yang L, Liu Z, Fleming JL, Haque SJ, Barnholtz-Sloan JS, Ligon KL, Beroukhim R, Robe P, Chakravarti A.
Cui T, et al. Among authors: mladkova n.
Oncogene. 2019 Apr;38(16):2923-2936. doi: 10.1038/s41388-018-0601-9. Epub 2018 Dec 17.
Oncogene. 2019.
PMID: 30559405
Free PMC article.